Trial intelligence / Profile preview

CAPTAF: Catheter Ablation vs Pharmacological Therapy for Atrial Fibrillation

2008-001384-11Phase 4Active

Start
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of sotalol, propafenone, disopyramide and amiodarone in Atrial fibrillation (AFib) (2 arms). Primary endpoint: General health-related quality of life at 12 months. Started Mar 2008; status: active.

02

Drugs

sotalolpropafenonedisopyramideamiodarone
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on 2008-001384-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001384-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call